# 5% Topical Ibuprofen (IBU) for Ankle Sprain

> **NCT01945034** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 304 (actual)

## Conditions studied

- Ankle Injuries

## Interventions

- **DRUG:** Topical IBU twice daily
- **DRUG:** Placebo twice daily
- **DRUG:** Topical IBU three times daily
- **DRUG:** Placebo three times daily

## Key facts

- **NCT ID:** NCT01945034
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945034, "5% Topical Ibuprofen (IBU) for Ankle Sprain". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01945034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*